LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
44 hedge funds and large institutions have $77.8M invested in La Jolla Pharmaceutical Company in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less funds holding
Funds holding: 54 → 44 (-10)
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
44
Holding in Top 10
3
Calls
$165K
Puts
$53K
Top Buyers
| 1 | +$2.6M | |
| 2 | +$312K | |
| 3 | +$306K | |
| 4 |
Bank of New York Mellon
New York
|
+$241K |
| 5 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
+$186K |
Top Sellers
| 1 | -$3.55M | |
| 2 | -$2.05M | |
| 3 | -$632K | |
| 4 |
Two Sigma Advisers
New York
|
-$307K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$281K |